Atherosclerosis Global Clinical Trials Review, H2, 2014: Order report by calling marketoptimizer.org at +1 888 391 5441 OR send an email on sales@marketoptimizer.org with Atherosclerosis Global Clinical Trials Review, H2, 2014 in subject line and your contact details. Atherosclerosis (also known as arteriosclerotic vascular disease or ASVD) is a specific form of arteriosclerosis in which an artery wall thickens as a result of invasion and accumulation of white blood cells (termed "fatty streaks" early on because of appearance being similar to that of marbled steak) and containing both living active WBCs (called inflammation) and remnants of dead cells, including cholesterol and triglycerides, eventually calcium and other crystallized materials, within the outer-most and oldest plaque. “Atherosclerosis Global Clinical Trials Review, H2, 2014″ provides data on the Atherosclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atherosclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atherosclerosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Complete report available at http://www.marketoptimizer.org/atherosclerosis-global-clinical-trialsreview-h2-2014.html . Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Inquire for discount @ www.marketoptimizer.org/contacts/discount?rname=9995 . (Report price: Single user license- US$ 2500 ) Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Atherosclerosis 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Atherosclerosis to Cardiovascular Clinical Trials 15 Buy a Copy of Report @ http://www.marketoptimizer.org/contacts/purchase?rname=9995 . Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Atherosclerosis to Cardiovascular Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Unaccomplished Trials of Atherosclerosis 25 Subjects Recruited Over a Period of Time 31 Clinical Trials by Sponsor Type 32 Prominent Sponsors 33 Top Companies Participating in Atherosclerosis Therapeutics Clinical Trials 34 Contact sales@marketoptimizer.org / Call +1 888 391 5441 for further information on “Atherosclerosis Global Clinical Trials Review, H2, 2014� report OR for any other market research and intelligence needs you may have for your business.